Coming Soon: D038 Carrier Plus for Expanded Carrier Status Determination in Challenging Genomic Regions
When it comes to copy number changes in highly homologous genomic regions, standard sequencing approaches don't always provide the complete picture.
Purpose-built for this challenge, our digitalMLPA™ NXtec Carrier Panels deliver accurate carrier status determination for disorders where CNVs play a key role, even within highly complex genomic regions. By combining the specificity of MLPA with the scale of NGS, these panels enable reliable analysis of challenging targets such as SMN1/SMN2, CYP21A2, HBA1/HBA2, and DMD.
Building on the foundation of the NXtec D028 Carrier Panel 1, the upcoming digitalMLPA NXtec D038 Carrier Plus goes one step further, expanding the coverage with 16 additional inherited disorders such as Fragile X syndrome, phenylketonuria, and many more.
Providing broader insights across a wider range of conditions, D038 Carrier Panel Plus offers:
- Broad coverage with targets for 26 inherited conditions
- High specificity even in homologous regions
- Robust copy number determination
- Simple data analysis using dedicated software, with no bioinformatics expertise required
Be the first to be notified when D038 Carrier Plus becomes available!
SIGN UP FOR D038 NOTIFICATIONS
Available Now: NXtec D028 Carrier Panel 1
NXtec D028 Carrier Panel 1 – the original assay the expanded panel is based on – targets 10 common inherited conditions, including SMA, DMD, alpha- and beta-thalassemia, CAH and cystic fibrosis.